Keyphrases
Granulomatosis with Polyangiitis
83%
Swan-Ganz Catheter
83%
Monotherapy
83%
National Cohort Study
83%
Diuretics
83%
Atrial Fibrillation or Flutter
83%
Short-term Mortality
83%
Serum Potassium
83%
Lymphoma Patients
83%
Anthracyclines
83%
Cardiotoxicity
83%
Combined Antihypertensive Therapy
83%
Beta-blockers
66%
Mortality Risk
66%
Congestive Heart Failure
52%
R-CHOP
52%
Digoxin
49%
Potassium
49%
6-cycle
41%
Verapamil
33%
Amiodarone
33%
Potassium Levels
33%
90-day Mortality
33%
Confidence Interval
31%
CHOEP
31%
Flow Probe
30%
All-cause Mortality
27%
Heart Disease
20%
5-cycle
20%
Hypokalemia
16%
Group Risk
16%
Hypo
16%
Co-treatment
16%
Hyperkalemia
16%
Sotalol
16%
Multivariable Cox Regression
16%
Diuretic Therapy
16%
Relative Contribution
10%
Previous History
10%
Diffuse Large B-cell Lymphoma (DLBCL)
10%
Polytherapy
10%
Rituximab
10%
Cyclophosphamide
10%
Immunochemotherapy
10%
Etoposide
10%
Competing Risks
10%
Lymphoma Therapy
10%
Follicular Lymphoma
10%
Adult Patients
10%
Chemotherapy Regimen
10%
Pharmacology, Toxicology and Pharmaceutical Science
Isotopes of Potassium
100%
Hypokalemia
97%
Cardiotoxicity
83%
Antihypertensive Therapy
83%
Cohort Study
83%
Diuretic Agent
83%
Anthracycline
83%
Thiazide Diuretic Agent
83%
Heart Atrium Flutter
83%
Atrial Fibrillation
83%
Monotherapy
69%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
62%
Renin-Angiotensin System Inhibitor
58%
Calcium Channel Blocker
58%
Beta Adrenergic Receptor Blocking Agent
55%
Congestive Heart Failure
52%
Digoxin
41%
Verapamil
27%
Amiodarone
27%
Combination Therapy
24%
All Cause Mortality
24%
Heart Disease
20%
Sotalol
13%
Hyperkalemia
13%
Chemotherapy
10%
Etoposide
10%
Follicular Lymphoma
10%
Chemotherapy Regimens
10%
Diffuse Large B Cell Lymphoma
10%
Antihypertensive Agent
8%
